Company profile: Oncotherapeutics
1.1 - Company Overview
Company description
- Provider of oncology-focused full-service CRO solutions: clinical trial management from protocol to data analysis; site and investigator management; biostatistics, clinical data management and EDC design; medical writing for protocols, regulatory documents and scientific publications; safety monitoring and reporting; and ONCOCAPTURE clinical sample collection and archiving.
Products and services
- Clinical Trial Management: Orchestrates oncology trials from protocol development through data analysis to ensure efficient, timely execution across phases using a full-service framework
- Data Management and Analysis: Delivers biostatistics, clinical data management, and EDC design to safeguard data integrity and compliance via an EDC-enabled, oncology-focused architecture
- Safety Monitoring and Reporting: Monitors and reports adverse events and safety data to ensure regulatory compliance through a regulatory-compliant, rigorously documented surveillance process
Key contacts
🔒
🔒
Financial details
🔒
1.2 - Competitors and similar companies to Oncotherapeutics
Konapharma
HQ: Switzerland
Website
- Description: Provider of contract manufacturing services specializing in the production of solid dosage forms.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Konapharma company profile →
VectorBuilder
HQ: United States
Website
- Description: Provider of an online platform for vector cloning and CRO services, including gene delivery design, development and optimization, vector customization, and clinical vector preparation. Offers custom vector design and cloning (plasmids, lentivirus, AAV), viral vector packaging, stable cell line engineering, mutation library construction, AAV capsid evolution, and drug-selection markers.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full VectorBuilder company profile →
Wacker Chemie
HQ: Germany
Website
- Description: Provider of silicone products (emulsions, rubber, silica) for electronics and automotive; polymer solutions for construction, adhesives and coatings; high-purity polysilicon for semiconductor and solar; biotechnology products and services including biopharmaceuticals and food ingredients; plus technical competence centers offering expert advice and product development support.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Wacker Chemie company profile →
Eurogentec
HQ: Belgium
Website
- Description: Provider of GMP biopharmaceutical manufacturing and life science solutions for research, diagnostic and pharmaceutical markets, including large-scale production of plasmid DNA, recombinant proteins, antibody fragments, mRNA, vaccines and conjugates; complex and NGS oligonucleotides; peptide-oligo conjugates; custom RNA/DNA aptamers; reagents and kits, in compliance with local and international standards.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Eurogentec company profile →
Molecular Medicine
HQ: United States
Website
- Description: Provider of process R&D, process and assay development, clinical manufacturing, fill/finish, and GMP storage services.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Molecular Medicine company profile →
🔒
2.M&A buyers
2.1 Potential strategic acquirers in the sector
🔒
🔒
🔒
🔒
View all strategic buyers with complete profiles
Start Free Trial →
2.2 - Strategic buyer groups for Oncotherapeutics
🔒
Buyer group 1: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔒
Buyer group 2: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔒
Buyer group 3: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔓 Unlock all detailed buyer group breakdowns with complete company profiles
Start Free Trial →
3. Investors and private equity firms
3.1 - Buyout funds investing in similar companies to Oncotherapeutics
2.2 - Growth funds investing in similar companies to Oncotherapeutics
🔒
View all growth equity funds with complete profiles
Start Free Trial →
4 - Top valuation comps for Oncotherapeutics
4.2 - Public trading comparable groups for Oncotherapeutics
🔓 Unlock all public trading comparable groups with complete valuation data
Start Free Trial →